ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Foresee Pharmaceuticals Announces Completion of US$47 Million Financing
December 25, 2020Foresee pharmaceuticals announces that it has successfully completed an underwritten public offering of 15,000,000 shares of its common stock to the public at a price of NT$88 per share. -
Foresee Pharmaceuticals Announces NDA for CAMCEVI(TM) 42MG Accepted for Review by the FDA
October 10, 2020Foresee Pharmaceuticals Co., Ltd. announced that the 505(b)(2) New Drug Application (NDA) for FP-001 LMIS 50mg, or CAMCEVI™ 42MG, a ready-to-use 6-month depot formulation of leuprolide mesylate, has been accepted for review by the U.S. Food and Drug ...
Pharma Sources Insight January 2025
